AgeX Therapeutics, Inc. (AGE)

Operating Cash Flow Growth

-78.24%

Quarterly · Period ending:

AGE logo

AGE Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-78.24%
AGE Quarterly Cash from Operations YoY % (-30.57% → -78.24%)
High-resolution chart · PNG

AGE operating cash flow growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. Operating Cash Flow Growth — Quarterly
Period endingOperating Cash Flow Growth
-78.24%
-5.6918%
48.1879%
56.8337%
-174.0647%
-467.4464%
-378.4871%
100%
15.4424%
-55.3369%
-50.8091%
-15.6357%
-13.9976%
19.7936%
34.3949%
-3.0697%
37.7947%
-1.6667%
0.2647%
24.5098%
-27.4225%
32.808%
20.3626%
18.6662%
21.1612%
-17.8397%
-33.0342%
-27.6724%
-30.5736%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.